7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 
      
    		                                           
      operating activities
    		                                           
      net income
    		31,507,000 11,983,000 2,417,000 12,536,000 9,335,000 19,606,000 27,713,000 31,940,000 20,634,000 13,007,000 -17,426,000 -7,199,000 457,000 -5,191,000 -13,069,000 -25,034,000 8,046,000 72,843,000 15,662,000 6,958,000 11,286,000 8,058,000 450,000 -2,201,000 -6,109,000 -4,712,000 -9,700,000 9,086,000 -16,502,000 -13,060,000 -18,652,000 -17,403,000 -13,263,000 -21,121,000 -23,078,000 -27,559,000 -26,445,000 -24,519,000 -15,653,000 -9,525,000 -9,361,000 -4,675,000 -3,694,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                           
      amortization expense
    		55,473,000 55,473,000 55,473,000  40,801,000 34,515,000 34,517,000  36,317,000 37,463,000 37,466,000  37,552,000 37,501,000 18,923,000 16,795,000 16,796,000 16,795,000 16,795,000 16,795,000 16,795,000 16,795,000 10,295,000        29,526,000             
      depreciation expense
    		1,033,000 1,135,000 1,091,000 1,041,000 946,000 952,000 917,000 949,000 835,000 895,000 817,000 825,000 488,000 656,000 715,000 424,000 448,000 425,000 439,000 281,000 195,000 196,000 198,000        482,000             
      deferred income taxes
    		-12,132,000 -2,914,000 -539,000 -10,156,000 -8,733,000 -3,513,000 -4,412,000 -338,000 -1,133,000 -636,000 -46,000 -1,078,000 2,097,000 -3,372,000 -6,038,000 -15,016,000 -377,000                           
      stock-based compensation expense
    		9,811,000 10,818,000 11,524,000 7,596,000 7,317,000 10,012,000 7,475,000 7,002,000 7,027,000 7,072,000 6,035,000 5,670,000 5,377,000 5,692,000 6,135,000 4,912,000 5,948,000 6,516,000 6,879,000 6,210,000 5,165,000 5,584,000 4,951,000 3,966,000 4,137,000 4,162,000 4,263,000 3,598,000 3,926,000 3,526,000 2,728,000 2,078,000 2,100,000 1,946,000 1,821,000 1,650,000 1,641,000 1,395,000 1,101,000 992,000 503,000 601,000 113,000 
      non-cash lease expense
    		          -105,000 -103,000 -88,000 271,000 158,000 -2,000 5,000 8,000 7,000 8,000 13,000 18,000 18,000 -96,000 180,000 115,000 114,000                 
      non-cash interest expense for amortization of debt discount and issuance costs
    		1,343,000 1,355,000 1,367,000 1,424,000 1,208,000 1,604,000 1,780,000 1,963,000 2,124,000 2,261,000 2,287,000 2,383,000 2,467,000 2,522,000 913,000 779,000 832,000 876,000 919,000 2,545,000 2,567,000 2,524,000 1,336,000                     
      net accretion for deferred royalty obligation
    		-348,000 1,105,000 909,000                                         
      loss on extinguishment of debt
    		   0 4,145,000   0 0 0 23,504,000                                 
      net amortization of premiums and discounts on investments
    		-230,000 -264,000 -324,000 -376,000 -514,000 -723,000 -415,000 -568,000 -569,000                                   
      change in fair value of contingent consideration
    		-19,000 -358,000 -786,000                                         
      changes in operating assets and liabilities:
    		                                           
      accounts receivable
    		-20,926,000 15,679,000 -170,000 106,000 -190,000 -9,162,000 4,832,000 2,326,000 -14,372,000 11,647,000 3,993,000 12,283,000 2,102,000 -31,159,000 -5,006,000 43,155,000 -58,901,000 3,058,000 -9,836,000 -6,854,000 4,729,000 4,232,000 -12,474,000 11,427,000 -3,101,000 3,860,000 -7,193,000 -11,667,000 1,847,000 -2,344,000 -56,067,000 -4,146,000 -946,000 -1,528,000 -1,220,000 -450,000 1,273,000       
      inventory
    		96,000 -930,000 -1,658,000 2,472,000 6,985,000 3,414,000 1,056,000 1,793,000 -8,099,000 6,869,000 13,606,000 18,150,000 13,117,000 16,677,000 330,000 -36,000 2,238,000 -4,098,000 -400,000 1,045,000 470,000 -3,071,000 -6,714,000 -883,000 1,193,000                   
      prepaid expenses and other assets
    		21,337,000 -10,848,000 -10,272,000 -1,948,000 -434,000 -11,511,000 -177,000 1,397,000 1,791,000 -1,511,000 -238,000 -5,604,000 753,000 -432,000 677,000 -2,316,000 2,531,000 -1,186,000 -115,000 -1,637,000 2,044,000 985,000 -2,990,000 -277,000 1,805,000 433,000 76,000 -1,689,000 2,131,000 -85,000 -523,000 -1,024,000 1,050,000 -935,000 -148,000 -809,000        
      accounts payable
    		-3,283,000 -6,963,000 13,919,000 810,000 -5,944,000 -3,608,000 -2,536,000 4,955,000 1,181,000 -573,000 -502,000 -4,143,000 1,010,000 2,776,000 -350,000 -3,541,000 186,000 -1,122,000 -1,350,000 3,525,000 -1,691,000 2,043,000 -108,000 -5,734,000 1,040,000 -2,792,000 1,583,000 470,000 -7,013,000 9,356,000 3,652,000 702,000 -630,000 -1,181,000 -2,313,000 168,000 2,864,000 -114,000 2,651,000 336,000 930,000   
      accrued liabilities
    		-8,114,000 5,587,000 -17,673,000 22,422,000 -62,934,000 322,000 660,000 5,107,000                                    
      accrued rebates, returns and discounts
    		2,432,000 -8,389,000 150,000 -7,053,000 -1,437,000 18,328,000 -9,451,000 -17,680,000 31,922,000 12,187,000 -29,589,000 -10,726,000 -5,502,000 15,327,000 -21,865,000 5,273,000 48,499,000 -12,929,000 -401,000 -13,692,000 -807,000 -833,000 14,337,000 -7,714,000 6,999,000 5,936,000 7,545,000 14,583,000 22,664,000 15,391,000 53,955,000             
      operating lease assets and liabilities
    		           0 -1,000           0 0                   
      deferred revenue
    		                               0 -10,361,000 1,666,000 3,751,000 1,006,000 12,000       
      net cash from operating activities
    		78,438,000 72,439,000 55,398,000 84,644,000 -8,999,000 67,398,000 61,937,000 73,338,000 74,018,000 99,722,000 27,671,000 66,325,000 42,769,000 40,451,000 -25,315,000 36,198,000 17,254,000 29,535,000 20,570,000 22,577,000 34,180,000 43,854,000 -6,669,000 15,656,000 6,069,000 14,627,000 -8,569,000 42,288,000 41,834,000 55,605,000 29,663,000 -13,296,000 -12,567,000 -17,467,000 -23,688,000 -23,287,000 -19,414,000 -20,836,000 -11,516,000 -8,939,000    
      capex
    		2,000 -65,000 -798,000 -570,000 -244,000 -270,000 -568,000 -41,000 -65,000 -56,000 -176,000 -940,000 42,000 -504,000 40,000 -744,000 -30,000 -1,230,000 132,000 -1,926,000 -3,220,000 337,000 -444,000 -1,307,000 -1,311,000 -875,000 -2,513,000 32,000 -2,445,000 424,000 -227,000 -53,000 -547,000 -244,000 70,000 -341,000 -111,000 0 0 -187,000    
      free cash flows
    		78,440,000 72,374,000 54,600,000 84,074,000 -9,243,000 67,128,000 61,369,000 73,297,000 73,953,000 99,666,000 27,495,000 65,385,000 42,811,000 39,947,000 -25,275,000 35,454,000 17,224,000 28,305,000 20,702,000 20,651,000 30,960,000 44,191,000 -7,113,000 14,349,000 4,758,000 13,752,000 -11,082,000 42,320,000 39,389,000 56,029,000 29,436,000 -13,349,000 -13,114,000 -17,711,000 -23,618,000 -23,628,000 -19,525,000 -20,836,000 -11,516,000 -9,126,000    
      investing activities
    		                                           
      acquisition of ironshore
    		   0                                        
      purchases of property and equipment
    		-188,000 -65,000 -798,000 -570,000 -244,000 -270,000 -568,000 -164,000 -65,000 -56,000 -176,000 -940,000 -113,000 -461,000 -108,000 -515,000 -276,000 -725,000 -428,000 -1,481,000 -2,403,000 -826,000 -836,000 -889,000 -1,351,000 -875,000 -3,323,000 -1,773,000 -2,717,000 -631,000 -356,000 -172,000 -340,000 -449,000 -29,000 -341,000 -111,000   -187,000    
      purchases of marketable securities
    		-45,245,000 -16,611,000 -25,890,000 -27,168,000 -10,600,000 -34,293,000 -39,110,000 -40,933,000 -9,757,000                                   
      maturities of marketable securities
    		14,565,000 13,761,000 17,008,000 15,976,000 29,419,000 25,657,000 21,550,000 16,000,000                                    
      net cash from investing activities
    		-30,868,000 -2,915,000 -9,680,000 -11,762,000 -248,963,000 -8,906,000 -18,128,000 -25,097,000 -3,822,000 -41,717,000 -176,000 -940,000 -113,000 -461,000 -572,177,000 -515,000 -276,000 -725,000 -428,000 -1,481,000 -2,403,000 -2,241,000 -367,647,000 -889,000 -1,351,000 -875,000 -3,323,000 -1,773,000 -2,717,000 -747,000 -19,117,000 -172,000 -340,000 -449,000 -29,000 -341,000 -111,000   -187,000    
      financing activities
    		                                           
      proceeds from issuances of common stock from employee stock purchase plan
    		857,000 0 506,000  471,000 0 356,000  291,000 0 169,000                                 
      proceeds from the exercise of stock options
    		1,435,000 308,000 1,552,000 173,000 149,000 5,719,000 4,205,000 3,240,000 302,000 1,251,000 3,848,000 6,863,000 142,000 1,545,000 3,261,000 2,339,000 1,339,000 4,092,000 4,182,000 183,000 314,000 1,626,000 4,454,000 1,515,000 232,000 86,000 213,000 168,000 182,000 1,532,000 2,373,000 308,000 13,000 321,000 94,000 329,000 28,000 44,000 42,000 45,000 1,000   
      payments made for employee stock tax withholdings
    		-964,000 -428,000 -10,593,000 -279,000 -142,000 -5,875,000 -12,874,000 -233,000 -172,000 -220,000 -7,736,000 -45,000 -106,000 -511,000 -3,382,000 0 -220,000 -421,000 -3,508,000                         
      repurchases of common stock, including the asr agreement
    		0    0                                       
      repayment of term notes
    		-16,146,000 -16,146,000 -16,146,000 -16,146,000 0 -45,834,000 -45,833,000 -45,833,000 -45,834,000 -45,833,000 -25,000,000 -25,000,000 -25,000,000   -12,500,000 -12,500,000 -12,500,000 -12,500,000 -12,500,000 -12,500,000                       
      proceeds from term note modification, net of fees paid to lender of 11,825
    		   0                                        
      redemption of 2026 convertible notes, including premium and redemption costs
    		   0 -27,000                                       
      repayment of assumed debt from ironshore acquisition
    		   0                                        
      payments made for deferred purchase price for acquisition
    		0 -7,000,000 -555,000                                         
      net cash from financing activities
    		-14,818,000 -48,370,000 -25,236,000 -41,277,000 149,028,000 -114,208,000 -54,146,000 -67,826,000 -95,413,000 -45,236,000 68,297,000 -25,823,000 -31,252,000 -23,966,000 517,764,000 -42,498,000 -26,508,000 -8,829,000 -11,468,000 -12,403,000 -12,032,000 -12,211,000 323,120,000 1,414,000 407,000 51,000 169,000 -33,672,000 -33,074,000 -50,063,000 -388,000 24,554,000 9,309,000 -433,000 50,000 85,825,000 -194,000 -622,000 50,549,000 -637,000 -265,000 71,858,000 45,036,000 
      ​
    		                                           
      net increase in cash, cash equivalents and restricted cash
    		32,752,000 21,154,000 20,482,000 31,605,000 -108,934,000 -55,716,000 -10,337,000 -19,585,000 -25,217,000 12,769,000 95,792,000 39,562,000 11,404,000 16,024,000 -79,728,000 -6,815,000 -9,530,000 19,981,000 8,674,000 8,693,000 19,745,000   16,181,000 5,125,000 13,803,000 -11,723,000 6,843,000 6,043,000 4,795,000 10,158,000             
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 96,612,000  0 0 239,994,000  0 0 176,235,000  0 0 188,973,000 0 0 0 176,663,000 0 0 0 170,019,000 0 0 0 146,633,000 0 0 0 118,794,000             
      cash, cash equivalents and restricted cash at end of period
    		32,752,000 21,154,000 117,094,000  -108,934,000 -55,716,000 229,657,000  -25,217,000 12,769,000 272,027,000  11,404,000 16,024,000 109,245,000 -6,815,000 -9,530,000 19,981,000 185,337,000 8,693,000 19,745,000 29,402,000 118,823,000 16,181,000 5,125,000                   
      reconciliation of cash, cash equivalents and restricted cash to the condensed consolidated balance sheets:
    		                                           
      cash and cash equivalents
    		32,748,000 21,156,000 96,192,000 31,605,000 -133,934,000 -55,716,000 228,610,000 -19,585,000 -25,217,000 14,269,000 269,480,000 39,562,000 11,404,000 16,024,000 106,698,000 -6,815,000 -9,530,000 19,981,000 182,790,000 8,693,000 19,745,000 29,500,000 116,178,000                     
      restricted cash
    		4,000 -2,000 20,902,000 0 25,000,000 0 1,047,000 0 0 -1,500,000 2,547,000 0 0 0 2,547,000 0 0 0 2,547,000 0 0 -98,000 2,645,000                 0    
      total cash, cash equivalents and restricted cash
    		32,752,000 21,154,000 117,094,000 31,605,000 -108,934,000 -55,716,000 229,657,000 -19,585,000 -25,217,000 12,769,000 272,027,000 39,562,000 11,404,000 16,024,000 109,245,000 -6,815,000 -9,530,000 19,981,000 185,337,000 8,693,000 19,745,000 29,402,000 118,823,000                     
      supplemental disclosure of cash flow information
    		                                           
      cash paid for interest
    		21,526,000 13,847,000 21,694,000 15,224,000 17,668,000 12,074,000 17,468,000 15,577,000 20,492,000 17,688,000 19,499,000 17,248,000 17,528,000 11,919,000 5,833,000 3,035,000 5,225,000 3,602,000 5,746,000 4,249,000 6,459,000 4,803,000 3,456,000 166,000 181,000 184,000 178,000 173,000 167,000 133,000 109,000 18,000 33,000 39,000 49,000 58,000 67,000 76,000 83,000 93,000 58,000 101,000 101,000 
      cash paid for income taxes
    		15,488,000 29,817,000 2,456,000 621,000 15,588,000 35,708,000 173,000 6,912,000 7,282,000 9,268,000 743,000 363,000 3,261,000 4,662,000 2,114,000 676,000 1,453,000 458,000 418,000                         
      supplemental disclosure of non-cash activities
    		                                           
      acquisition of property and equipment included in accounts payable and accrued liabilities
    		190,000                                           
      contingent consideration
    		                                           
      business combination consideration payable
    		   0                                        
      non-cash lease benefit
    		 -30,000 -30,000  -23,000 -22,000 -22,000                                     
      miscellaneous costs of redemption of 2026 convertible notes
    		                                           
      amortization and impairment expense
    		                                           
      non-cash lease (benefit) expense
    		       -22,000 -45,000                                   
      non-cash interest expense for deferred royalty obligation
    		   3,240,000                                        
      non-cash change in fair value of contingent consideration
    		                                           
      acquisition of bdsi
    		           0 0 0 -572,069,000                             
      proceeds from issuances of common stock from employee stock purchase plans
    		           0 134,000 0 203,000 0 397,000 0 358,000 0 401,000 0 357,000 0 373,000 0 444,000 0 607,000 0 510,000 0 468,000 0 673,000         
      repurchases of common stock
    		           -7,641,000                                
      proceeds from issuances of 2029 convertible notes, net of issuance costs of 6,280
    		       0 0                                   
      repurchase of 2026 convertible notes, including premium
    		       0 0 0 -138,638,000                                 
      cash, cash equivalents and restricted cash at beginning of year
    		                                           
      cash, cash equivalents and restricted cash at end of year
    		                                           
      reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:
    		                                           
      acquisition of property and equipment in accounts payable and accrued liabilities
    		       123,000                                    
      excise tax on share repurchases in accrued liabilities
    		                                           
      acquisition date fair value of contingent consideration
    		                                           
      proceeds from issuances of 2029 convertible notes, net of issuance costs of 5,846
    		          235,654,000                                 
      note issuance costs in accounts payable and accrued liabilities
    		                                           
      proceeds from term note modification
    		           0 0 0 517,682,000                             
      inventory used in the construction and installation of property and equipment
    		               0 0 0 516,000 487,000 1,199,000 219,000 394,000                     
      accrued expenses
    		         11,247,000 -12,131,000 13,588,000 -17,060,000 -821,000 -6,838,000 10,805,000 -8,997,000 10,998,000 -8,029,000 7,393,000 -6,586,000 7,323,000 -15,968,000 13,284,000 -3,943,000 4,978,000 -8,263,000 7,814,000 -2,736,000 5,017,000 8,900,000 -10,842,000 9,241,000 3,595,000 -2,521,000 2,161,000 1,101,000 3,323,000 -15,000 -453,000   872,000 
      acquisition of property and equipment in accounts payable and accrued expenses
    		            155,000 -43,000 148,000 -229,000 246,000 -505,000 560,000 -445,000 -817,000 1,163,000 392,000 -418,000 40,000                   
      note issuance costs in accounts payable and accrued expenses
    		          434,000                                 
      purchase of intangible asset
    		                   0 0 -1,415,000 -366,811,000                     
      proceeds from issuance of term note, net of issuance costs of 2,456
    		                   0 0                       
      proceeds from convertible senior notes, net of issuance costs of 5,473
    		                   0 0                       
      repayment of term loan
    		                   0 0 0 -11,500,000                     
      accrued royalties discharged upon closing of asset acquisition
    		                   0 0 0 1,145,000                     
      receivable from stock option exercises in other current assets
    		                        0 -28,000 33,000                 
      accrued repurchases of common stock
    		                                           
      other long-term liabilities
    		                       0 0 0 -676,000                 
      cash paid for offering costs
    		                           0 0 0 30,000 781,000 360,000    0 128,000 384,000     
      operating lease assets assumed
    		                       0 0 0 9,957,000                 
      operating lease liabilities assumed
    		                       0 0 0 10,691,000                 
      proceeds from issuance of term note, net of issuance costs of 2,200
    		                      192,373,000                     
      proceeds from convertible senior notes, net of issuance costs of 4,956
    		                      138,794,000                     
      asset acquisition transaction costs in accounts payable and accrued expenses
    		                      1,415,000                     
      term notes issuance costs in accounts payable and accrued expenses
    		                      256,000                     
      convertible senior notes issuance costs in accounts payable and accrued expenses
    		                      517,000                     
      non-cash interest expense for nucynta asset acquisition
    		                                           
      payments made for employee restricted stock tax withholdings
    		                   -86,000 -247,000 -564,000 -1,358,000 -101,000 -198,000 -35,000 -488,000 -90,000 -114,000 -140,000 -216,000 0 -17,000 0 -51,000         
      proceeds from issuance of common stock from public offerings, net of issuance costs of -, - and 30, respectively
    		                                           
      proceeds from term loan amendment, net of repayment of amended term loan
    		                            1,000 0 10,020,000             
      repayment of asset acquisition obligations
    		                           -33,750,000 -33,750,000 -51,455,000 -13,045,000             
      liabilities assumed from nucynta asset acquisition included in accrued rebates, returns and discounts
    		                                           
      liabilities assumed from nucynta asset acquisition included as a reduction to accounts receivable
    		                                           
      warrant issued in connection with nucynta asset acquisition
    		                                           
      net decrease in cash, cash equivalents and restricted cash
    		                      -51,196,000                     
      amortization expense for nucynta asset acquisition
    		                       3,688,000 3,688,000 3,688,000 3,688,000                 
      depreciation and amortization, excluding nucynta asset acquisition
    		                       196,000 180,000 171,000 184,000                 
      non-cash impairment charges
    		                                           
      lease incentive obligation
    		                                           
      upfront cash paid for nucynta asset acquisition
    		                                           
      proceeds from issuances of common stock from public offerings, net of issuance costs of -, 30 and 1,198, respectively
    		                                           
      cash paid for common stock offerings costs
    		                            0 0 -30,000             
      offering costs in accrued expenses
    		                             0 25,000 -5,000 35,000 -87,000 112,000         
      non-cash interest expense
    		                           2,169,000 5,641,000 5,943,000 5,528,000             
      inventories
    		                          -924,000 1,412,000 -685,000 -642,000 134,000 -412,000 119,000 -25,000 -179,000 260,000 -362,000       
      operating lease asset and liabilities
    		                          734,000                 
      cash, and cash equivalents and restricted cash at end of period
    		                          134,910,000 6,843,000 6,043,000 4,795,000 128,952,000             
      acquisition of property and equipment in accrued expenses
    		                          810,000 1,805,000 272,000 1,055,000 129,000 119,000 -207,000 205,000 99,000         
      asset acquisition transaction costs in accrued expenses
    		                              116,000             
      upfront cash paid for onsolis asset acquisition
    		                                           
      proceeds from issuances of common stock from public offerings, net of issuance costs of 30, 1,198 and 845, respectively
    		                                           
      proceeds from term loan amendment
    		                                           
      nucynta amortization expense
    		                            32,407,000               
      depreciation and other amortization expense
    		                            154,000               
      cash paid for asset acquisition
    		                            0 -116,000 -18,761,000             
      proceeds from issuances of common stock from public offerings, net of issuance costs of 0 and 507
    		                                           
      receivable from issuance of common stock from at-the-market offering in other current assets
    		                                           
      liabilities assumed from asset acquisition in accrued rebates, returns and discounts
    		                            0 0 22,660,000             
      repayment of term note
    		                               -667,000 -667,000 -667,000 -666,000 -667,000 -667,000 -666,000 -667,000     
      depreciation and amortization
    		                               130,000 132,000 124,000 208,000 295,000 273,000 44,000 43,000 41,000 38,000 46,000 46,000 
      refundable pdufa fee
    		                                       0 0 0 2,335,000 
      purchase of intangible assets
    		                                   0 0       
      proceeds from issuances of common stock from public offerings, net of issuance costs of 1,198, 845 and 2,408, respectively
    		                                           
      proceeds from issuance of series d convertible redeemable preferred stock, net of issuance costs of 193
    		                                       0 0 0 44,807,000 
      repayment of lease note payable
    		                                       -15,000    
      net increase in cash and cash equivalents
    		                               11,086,000 -3,598,000 -18,349,000 -23,667,000 62,197,000 -19,719,000 -23,983,000 39,033,000 -9,763,000 -6,953,000 67,424,000 43,355,000 
      cash and cash equivalents at beginning of period
    		                               0 0 0 153,225,000 0 0 0 95,697,000 0 0 0 1,634,000 
      cash and cash equivalents at end of period
    		                               11,086,000 -3,598,000 -18,349,000 129,558,000 62,197,000 -19,719,000 -23,983,000 134,730,000 -9,763,000 -6,953,000 67,424,000 44,989,000 
      preferred stock conversion to common stock
    		                                       0 0   
      extinguishment of preferred stock
    		                                           
      accruals of dividends and accretion to redemption value
    		                                       0 0 23,346,000 1,226,000 
      conversion of bridge note to preferred stock
    		                                       0 0 0 5,000,000 
      lease incentive
    		                                -9,000   -9,000 -8,000   -9,000    
      proceeds from issuances of common stock from public offerings, net of issuance costs of 507 and 526
    		                                           
      proceeds from issuances of common stock from public offerings, net of issuance costs of 526
    		                                           
      payments of offering costs for at-the-market equity program
    		                                           
      non cash interest expense
    		                                       0    
      change in fair value of derivative liability
    		                                           
      proceeds from issuance of convertible bridge note
    		                                           
      proceeds from issuances of common stock from public offerings, net of issuance costs of 845 and 2,408
    		                                           
      proceeds from notes payable, net of original note payoff
    		                                           
      repayment of term note with proceeds of notes payable
    		                                           
      proceeds from issuance of common stock, net of issuance costs of 526 and 2,408
    		                                    445,000       
      prepaid expenses and other current assets
    		                                     -716,000 365,000 -321,000    
      accruals of offering costs
    		                                      128,000     
      proceeds from issuance of common stock, net of issuance costs of 526
    		                                      51,174,000     
      accrual of back end fees related to note payable
    		                                           
      proceeds from issuance of common stock, net of issuance costs of 2,408
    		                                       0 0   
      proceeds from issuance of series c convertible redeemable preferred stock, net of issuance costs of 45
    		                                           
      performance adjustment to series a and common shares
    		                                           
      (repayment of) borrowing from term note
    		                                           
      cash paid for taxes
    		                                        2,000 1,000 1,000 
      repayment of term note with proceeds of note payable
    		                                           
      proceeds from the exercise of common stock options
    		                                          460,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.